Oncology/Hematology
News, opinions and meeting coverage in oncology/hematology.
— High overall response rate, even though many were ineligible for trial leading to drug's approval
Latest in Oncology/Hematology
Substantial drops in cancer-specific mortality affirmed in Chinese trial
News, features, and commentary about cancer-related issues
Rates rose after USPSTF recommendation, but increase was uneven
Knowing what to look for can mean the difference between life and death
Rates rose after USPSTF recommendation, but increase was uneven
Knowing what to look for can mean the difference between life and death
Oncology/Hematology Case Studies
Rare condition can be deadly without early diagnosis and treatment
Nonspecific presentation impedes early diagnosis of rare indolent tumor in older man
Be aware of the potential for secondary malignancy in relation to LCH diagnosis, researchers urge
More in Oncology/Hematology
Health news and commentary gathered by 51˶ staff
Small study suggests large benefit for Lu-177 dotatate in intracranial disease
Many patients may prefer a self-collected swab over a speculum
Latest negative results emphasize "critical" aspect of immunotherapy timing
With 98% PFS at 2 years, standard RT plus cisplatin sets a higher bar for de-escalation
Health news and commentary gathered by 51˶ staff
Trial finds similar complication and recurrence rates with hypofractionated versus standard RT
Numerical advantage in randomized trial, non-randomized study misses noninferiority mark
Health news and commentary gathered by 51˶ staff
"It really shows us that we have two great options," expert says
Gastric cancer incidence was lower after adjusting for certain factors in post hoc analyses
Also in TTHealthWatch: AACR report on cancer
Despite problematic dataset, risk/benefit profile not favorable with PD-L1 expression below 1
An increase in microbial risk score based on 22 bacteria tied to a 50% increase in HNSCC risk
